APVO - Latest News
Aptevo Therapeutics Inc. (APVO), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.8M. Beta to the broader market is 1.68.
The article list below shows the most recent APVO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent APVO Headlines
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
accessnewswire.com - Oct 14, 2026
Next generation multispecific technology designed to coordinate innate and adaptive immune activity within the tumor microenvironment SEATTLE, WA / AC
Aptevo Therapeutics Inc. (NASDAQ:APVO) Stock Short Interest Rises 59.0%
defenseworld.net - Oct 1, 2026
Aptevo Therapeutics Inc. (NASDAQ: APVO - Get Free Report) was the target of a large growth in short interest during the month of September.
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
accessnewswire.com - Sep 24, 2026
Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human Testing Trispecifics Combine
Aptevo Therapeutics (NASDAQ:APVO) Share Price Passes Below 50 Day Moving Average – Should You Sell?
defenseworld.net - Sep 18, 2026
Aptevo Therapeutics Inc. (NASDAQ: APVO - Get Free Report)'s share price crossed below its 50-day moving average during trading on Thursday.
Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial
benzinga.com - Sep 3, 2026
Aptevo Therapeutics Inc. (NASDAQ:APVO) announced that its lead candidate mipletamig achieved a 93% clinical benefit rate when administered as a tripl
How News Affects APVO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track APVO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked APVO news questions
- What is the latest APVO news headline?
- The most recent APVO headline (Oct 14, 2026) is "Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the APVO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What APVO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual APVO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.